Bal Pharma shareholding pattern
BALPHARMA
70.2
0.87 (1.25%)Last updated on 1 Feb, 2026 | 15:28 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Summary
For Year 2025-26, Bal Pharma reports the following shareholding: Total Promoters at 50.86%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0.14%, Domestic Institutional Investors at 0%, and Retail at 49.01%. This breakdown provides a quick snapshot of ownership distribution for Bal Pharma in 2025-26.
Bal Pharma FAQs
As of 02-2026, the promoter shareholding in Bal Pharma stands at 50.86% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Bal Pharma is 0.14% and 0% respectively.
The retail shareholding of the Bal Pharma is 49.01%.
Changes in shareholding patterns of Bal Pharma can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Bal Pharma are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
